Evidence map›Paper›PMID 32431275›Full record

Trial reportThe American journal of tropical medicine and hygiene2020

Efficacy of a Spatial Repellent for Control of Malaria in Indonesia: A Cluster-Randomized Controlled Trial.

Din Syafruddin, Puji B S Asih, Ismail Ekoprayitno Rozi, Dendi Hadi Permana, Anggi Puspa Nur Hidayati, Lepa Syahrani, Siti Zubaidah, Dian Sidik, Michael J Bangs, Claus Bøgh and 9 more

Erratum issued 2 registry-linked trialsOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06122142 nawithdrawnnot on this mapstarted 2024, after this paper: background citation

Advancing Spatial Repellents for Malaria Control: Effectiveness and Cost-Effectiveness of a Spatial Repellent Under Operational Use in Northern Uganda

TypeinterventionalSponsorUniversity of Notre DameRan2024 to 2025Enrolled0ConditionsMalariaArmsTransfluthrin - delivery by paid study personnel, Transfluthrin - delivery by voucher system, Transfluthrin - delivery by village health teams
NCT07712263 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Integrating the Guardian Spatial Emanator Within AVENIR II

TypeinterventionalSponsorUniversity of California, San FranciscoRan2026 to 2028Enrolled150,000ConditionsMalariaArmsSpatial Emanator
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Efficacy of a spatial repellent for control ofProceedings of the National Academy of Sciences of the United States of America · 2022
    Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Din Syafruddin1Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Puji B S Asih1Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Ismail Ekoprayitno Rozi1Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Dendi Hadi Permana1Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Anggi Puspa Nur Hidayati1Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Lepa Syahrani1Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Siti Zubaidah1Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
Dian Sidik3Department of Epidemiology, Faculty of Public Health, Universitas Hasanuddin, Makassar, Indonesia.
Michael J Bangs4Public Health and Malaria Control, PT Freeport Indonesia, International SOS, Kuala Kencana, Papua, Indonesia.
Claus Bøgh5The Sumba Foundation, Public Health and Malaria Control, Bali, Indonesia.
Fang Liu6Department of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, Indiana.
Evercita C Eugenio6Department of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, Indiana.
Jared Hendrickson7Center for Computer Research, University of Notre Dame, Notre Dame, Indiana.
Timothy Burton8Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana.
J Kevin Baird9Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia.
Frank Collins7Center for Computer Research, University of Notre Dame, Notre Dame, Indiana.
John P Grieco8Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana.
Neil F Lobo8Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana.
Nicole L Achee8Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana.
University of Notre Dame · USEijkman Institute for Molecular Biology · IDHasanuddin University · IDOxford University Clinical Research Unit Indonesia

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cluster-randomized, double-blinded, placebo-controlled trial was conducted to estimate the protective efficacy (PE) of a spatial repellent (SR) against malaria infection in Sumba, Indonesia. Following radical cure in 1,341 children aged ≥ 6 months to ≤ 5 years in 24 clusters, households were given transfluthrin or placebo passive emanators (devices designed to release vaporized chemical). Monthly blood screening and biweekly human-landing mosquito catches were performed during a 10-month baseline (June 2015-March 2016) and a 24-month intervention period (April 2016-April 2018). Screening detected 164 first-time infections and an accumulative total of 459 infections in 667 subjects in placebo-control households, and 134 first-time and 253 accumulative total infections among 665 subjects in active intervention households. The 24-cluster protective effect of 27.7% and 31.3%, for time to first-event and overall (total new) infections, respectively, was not statistically significant. Purportedly, this was due in part to zero to low incidence in some clusters, undermining the ability to detect a protective effect. Subgroup analysis of 19 clusters where at least one infection occurred during baseline showed 33.3% (

Indexed as

HousingChild, PreschoolCyclopropanesDouble-Blind MethodFemaleFluorobenzenesHumansIndonesiaInfantInsecticidesInsect RepellentsMalariaMaleMosquito ControlMosquito VectorsCyclopropanesFluorobenzenesInsecticidesInsect Repellentstransfluthrin

Identifiers

PMID32431275
PMCPMC7356406
OpenAlexW3027852465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.